Currently, to enroll participants into pharmaceutical trials strenuous and costly procedures are applied to test whether participants meet inclusion criteria or not; this includes travel to clinics, costly brain imaging, invasive assessments, or costly f2f assessments with experts. Moreover, screening for such inclusion criteria in clinical...
-
July 14, 2019 (v1)PublicationUploaded on: December 4, 2022
-
April 2014 (v1)Journal article
International audience
Uploaded on: December 3, 2022 -
June 9, 2015 (v1)Journal article
International audience
Uploaded on: December 3, 2022 -
2015 (v1)Journal article
Over the last few years, the use of new technologies for the support of elderly people and in particular dementia patients received increasing interest. We investigated the use of a video monitoring system for automatic event recognition for the assessment of instrumental activities of daily living (IADL) in dementia patients. Participants (19...
Uploaded on: March 25, 2023 -
June 2, 2015 (v1)Journal article
Currently, the assessment of autonomy and functional ability involves clinical rating scales. However, scales are often limited in their ability to provide objective and sensitive information. By contrast, information and communication technologies may overcome these limitations by capturing more fully the functional as well as cognitive...
Uploaded on: March 25, 2023 -
June 11, 2019 (v1)Journal article
International audience
Uploaded on: December 4, 2022 -
2020 (v1)Publication
Objectives: Antidepressant use is often reported as a risk factor for Orthostatic Hypotension (OH), however this relationship has never been explored in those with mild/moderate Alzheimer Disease (AD), who may represent a particularly vulnerable cohort. Methods: We performed a cross-sectional analysis of baseline data from the NILVAD study....
Uploaded on: April 14, 2023